Abcam Wins ‘Best Use of Digital Media’ at Life Science Industry Awards
News Nov 19, 2014
Abcam plc. has won the Life Science Industry Award for the ‘Best use of digital media’. Hosted by Bioinformatics LLC, the awards were announced at a ceremony in Washington D.C. on November 18, in conjunction with the Society for Neuroscience Annual Meeting.
Abcam revolutionised the buying of antibodies through its innovative eCommerce platform. The Company continues to innovate through its digital channels to provide personalised, relevant content that anticipates consumer needs and enhances their experience and engagement.
Presented to the world’s top performing life science suppliers in 27 categories, the Life Science Industry Awards are recognised as a benchmark of excellence in the life science tools industry. Voted by an expert network of thousands of global scientists, The Science Advisory Board, the awards bring the voice of the customer into the voting process, backed up by rigorous scoring methodology, bringing these awards the highest degree of integrity.
Alan Hirzel, CEO of Abcam, commented: “We’re delighted to have been recognised for the ‘Best Use of Digital Media’ and nominated in a further six categories. Our consumer-driven digital marketing strategy means we stay at the forefront of consumer needs, to provide the best products and services to enable researchers to discover more.”
Study Reveals How MRSA Infection Compromises Lymphatic FunctionNews
Infections of the skin or other soft tissues with the hard-to-treat MRSA bacteria appear to permanently compromise the lymphatic system, which is crucial to immune system function. Investigators describe how MRSA infection impairs the ability of lymphatic vessels to pump lymphatic fluid to lymph nodes in mouse models, which may contribute to the frequent recurrences of MRSA infection experienced by patients.
Possible Biomarker to Identify Who Would Benefit from ImmunotherapyNews
While immunotherapy has made a big impact on cancer treatment, the fact remains that only about a quarter of patients respond to these treatments. In a new study, researchers examined tissue samples from melanoma and ovarian cancer patients treated with immunotherapies and found a link between the percentage of antigen-presenting cells expressing PD-L1 and an objective clinical response to treatment.READ MORE
Fight Against Cancer: Drug Combination Helps Kickstart the Immune SystemNews
Scientists from King's College London have found a way to boost the immune system to help it fight back against cancer.
The breakthrough involves the first ever use of a combination of chemotherapy and a drug being trialled as a treatment for neonatal jaundice, that together help kick start the body's natural defences.